Pharma supply chains shift focus to resilience and visibility
· Source: itln.in
In short
Pharmaceutical supply chains are increasingly prioritising resilience, risk management, and end-to-end visibility amid geopolitical uncertainties and rising transportation costs, shifting away from mere cost efficiency. Industry leaders emphasize supplier diversification, strategic inventory buffers, multimodal transportation, and the integration of AI to improve operational decision-making and mitigate vulnerabilities in upstream sourcing and logistics.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 41, 2026: AI Moves Supply Chains From Planning Toward Execution, But Data and Capacity Set the Pace
Tags: pharma, logistics, resilience, visibility, supply chain, AI